Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 8

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 8
---
 outside the United States are required to inform themselves about
and to observe any restrictions as to this offering and the distribution of this prospectus applicable to that jurisdiction.

<div align='center'>i

ABOUT THIS PROSPECTUS</div>

Throughout this prospectus, unless otherwise designated
or the context suggests otherwise,

| ● | all references to the “Company,” “60P,” the “registrant,” “we,” “our,” or “us” mean 60 Degrees Pharmaceuticals, Inc., a Delaware corporation, and majority owned subsidiary 60P Australia Pty Ltd, an Australian proprietary company limited by shares; |

| ● | all dollar or $ references, when used in this prospectus, refer to United States dollars. |

Except as otherwise indicated, all information
in this prospectus assumes that:

| ● | no shares of common stock have been issued pursuant to any warrants or options, including the Warrants and the Placement Agent Warrants. |

<div align='center'>TRADEMARKS</div>

Solely for convenience, our trademarks and tradenames
referred to in this prospectus, may appear without the ® or ™ symbols, but such references are not intended to indicate in any
way that we will not assert, to the fullest extent under applicable law, our rights to these trademarks and tradenames. All other trademarks,
service marks and trade names included or incorporated by reference into this prospectus or the accompanying prospectus are the property
of their respective owners.

<div align='center'>GLOSSARY OF SELECTED TERMS</div>

The following are definitions of certain terms
that are commonly used in the medical industry and in this prospectus:

| ● | “API” means active pharmaceutical ingredient, the active molecule contained in a pharmaceutical product. |

| ● | “Arakoda” means ARAKODA®, the 60P-owned and FDA-approved product to prevent malaria in travelers, which contains as its active pharmaceutical ingredient, Tafenoquine succinate. |

| ● | “Broad Spectrum of Activity” refers to a molecule or drug that is active against a range of different pathogens. |

<div align='center'>ii</div>

| ● | “Dengue” means a mosquito-borne viral disease occurring in tropical and subtropical areas. |

| ● | “EUA” means Emergency Use Authorization. |

| ● | “FDA” refers to the U.S. Food and Drug Administration. |

| ● | “G6PD” means glucose-6-phosphate dehydrogenase